摘要
分析艾普拉唑肠溶片应用于消化性溃疡患者的临床效果。选取日照港口医院2022年1月—2023年1月收治的200例消化性溃疡患者作为研究对象,将其平均分为甲组和乙组,每组各100例。甲组实施常规治疗,乙组在常规治疗基础上辅以艾普拉唑肠溶片治疗,比较两组患者的治疗效果。结果显示,乙组患者的血清炎性因子水平下降,治疗效果更佳(P<0.05)。研究发现,艾普拉唑肠溶片治疗消化性溃疡的效果更佳,可以显著降低患者血清炎性因子水平,缓解患者临床症状,值得推广。
Analyze the clinical efficacy of eprazole enteric coated tablets in patients with peptic ulcer.200 patients with peptic ulcer admitted to Rizhao Port Hospital from January 2022 to January 2023 were selected as the research subjects,and they were evenly divided into group A and group B,with 100 patients in each group.Group A received routine treatment,while Group B received eprazole enteric coated tablets in addition to routine treatment.The treatment effects of the two groups of patients were compared.The results showed that the serum infl ammatory factor levels in group B patients decreased,and the treatment effect was better(P<0.05).Research has found that eprazole enteric coated tablets have a better effect on treating peptic ulcers,signifi cantly reducing the levels of serum infl ammatory factors in patients,alleviating clinical symptoms,and are worth promoting.
作者
陈洪港
Chen Honggang(Rizhao Port Hospital,Rizhao,Shandong 276826)
出处
《科技与健康》
2023年第12期37-39,共3页
Technology and Health
关键词
艾普拉唑肠溶片
消化性溃疡
临床效果
血清炎性因子
指标观察
eprazole enteric coated tablets
peptic ulcer
clinical effects
serum infl ammatory factors
indicator observation
